Fifteen drugs, including Novo Nordisk's Ozempic and Wegovy, are slated for Medicare price negotiations under the Inflation ...

Novo Nordisk's Ozempic and Wegovy are among 15 drugs targeted for Medicare price negotiations in 2027. The U.S. aims to cut ...

Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...

Authenticated data presented in the Chronic Kidney Disease market report is based on findings of extensive primary and secondary research ...